{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:04:01Z","timestamp":1787987041248,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10557-021-07302-y","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:03:46Z","timestamp":1642637026000},"page":"1031-1038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Platelet Inhibition with Ticagrelor 60\u00a0mg Versus 90\u00a0mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-9912","authenticated-orcid":false,"given":"Raffaele","family":"Piccolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Avvedimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Enrico","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Dal Piaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Filippelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Morisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Marenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Serafino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Franzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"7302_CR1","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","volume":"72","author":"D Capodanno","year":"2018","unstructured":"Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72:2915\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"7302_CR2","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001\u201315.","journal-title":"N Engl J Med"},{"key":"7302_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045\u201357.","journal-title":"N Engl J Med"},{"key":"7302_CR4","first-page":"723","volume":"14","author":"P Capranzano","year":"2021","unstructured":"Capranzano P, Angiolillo DJ. Antithrombotic management of elderly patients with coronary artery disease. JACC: Cardiovasc Interv. 2021;14:723\u201338.","journal-title":"JACC: Cardiovasc Interv"},{"key":"7302_CR5","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCOUTCOMES.111.964395","volume":"5","author":"S Husted","year":"2012","unstructured":"Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, et al. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes. 2012;5:680\u20138.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"7302_CR6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372:1791\u2013800.","journal-title":"N Engl J Med"},{"key":"7302_CR7","first-page":"pvab042","volume":"11","author":"F Franchi","year":"2021","unstructured":"Franchi F, Rollini F, Been L, Maaliki N, Abou Jaoude P, Rivas A, et al. Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. Eur Heart J Cardiovasc Pharmacother. 2021;11:pvab042.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"7302_CR8","first-page":"1521","volume":"12","author":"D Sibbing","year":"2019","unstructured":"Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention. JACC: Cardiovasc Interv. 2019;12:1521\u201337.","journal-title":"JACC: Cardiovasc Interv"},{"key":"7302_CR9","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","volume":"62","author":"US Tantry","year":"2013","unstructured":"Tantry US, Bonello L, Aradi D, Price MJ, Jeong Y-H, Angiolillo DJ, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62:2261\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"7302_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jacc.2015.12.062","volume":"67","author":"RF Storey","year":"2016","unstructured":"Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Judge HM, Rollini F, et al. Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial. J Am Coll Cardiol. 2016;67:1145\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"7302_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/CIRCULATIONAHA.116.023402","volume":"134","author":"F Franchi","year":"2016","unstructured":"Franchi F, Rollini F, Aggarwal N, Hu J, Kureti M, Durairaj A, et al. Pharmacodynamic comparison of prasugrel versus ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease: the OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 study. Circulation. 2016;134:780\u201392.","journal-title":"Circulation"},{"issue":"98","key":"7302_CR12","first-page":"699","volume":"2012","author":"M Hanssen","year":"2010","unstructured":"Hanssen M, Cottin Y, Khalife K, Hammer L, Goldstein P, Puymirat E, et al. French registry on acute ST-elevation and non ST-elevation myocardial infarction FAST-MI 2010. Heart. 2010;2012(98):699\u2013705.","journal-title":"Heart"},{"key":"7302_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4244\/EIJ-D-16-00497","volume":"13","author":"R Piccolo","year":"2017","unstructured":"Piccolo R, Magnani G, Ariotti S, Gargiulo G, Marino M, Santucci A, et al. Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial. EuroIntervention. 2017;13:78\u201386.","journal-title":"EuroIntervention"},{"issue":"7","key":"7302_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4244\/EIJ-D-20-01197","volume":"17","author":"R Piccolo","year":"2021","unstructured":"Piccolo R, Oliva A, Avvedimento M, Franzone A, Windecker S, Valgimigli M, et al. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis. EuroIntervention. 2021;17(7):550\u201360.","journal-title":"EuroIntervention"},{"key":"7302_CR15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","volume":"395","author":"M Gimbel","year":"2020","unstructured":"Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, et al. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet. 2020;395:1374\u201381.","journal-title":"Lancet"},{"key":"7302_CR16","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/CIRCULATIONAHA.120.050645","volume":"142","author":"K Szummer","year":"2020","unstructured":"Szummer K, Montez-Rath ME, Alfredsson J, Erlinge D, Lindahl B, Hofmann R, et al. Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: insights from the SWEDEHEART Registry. Circulation. 2020;142:1700\u20138.","journal-title":"Circulation"},{"key":"7302_CR17","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.117.032180","volume":"137","author":"S Savonitto","year":"2018","unstructured":"Savonitto S, Ferri LA, Piatti L, Grosseto D, Piovaccari G, Morici N, et al. Comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization. Circulation. 2018;137:2435\u201345.","journal-title":"Circulation"},{"key":"7302_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCULATIONAHA.120.048770","volume":"142","author":"F Franchi","year":"2020","unstructured":"Franchi F, Rollini F, Been L, Briceno M, Maaliki N, Wali M, et al. Pharmacodynamic and pharmacokinetic effects of a low maintenance dose ticagrelor regimen versus standard dose clopidogrel in diabetes mellitus patients without previous major cardiovascular events undergoing elective percutaneous coronary intervention. Circulation. 2020;142:1500\u20132.","journal-title":"Circulation"},{"key":"7302_CR19","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/CIRCULATIONAHA.118.034790","volume":"138","author":"RC Orme","year":"2018","unstructured":"Orme RC, Parker WAE, Thomas MR, Judge HM, Baster K, Sumaya W, et al. Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease. Circulation. 2018;138:1290\u2013300.","journal-title":"Circulation"},{"key":"7302_CR20","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jacc.2017.08.018","volume":"70","author":"G Giustino","year":"2017","unstructured":"Giustino G, Mehran R, Dangas GD, Kirtane AJ, Redfors B, G\u00e9n\u00e9reux P, et al. Characterization of the average daily ischemic and bleeding risk after primary PCI for STEMI. J Am Coll Cardiol. 2017;70:1846\u201357.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-021-07302-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T08:07:52Z","timestamp":1695370072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-021-07302-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["7302"],"URL":"https:\/\/doi.org\/10.1007\/s10557-021-07302-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"10 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The final study protocol and informed consent have been reviewed and approved by the institutional ethics committee and by the Italian Medicines Agency (EudraCT 2019\u2013002391-13). This study is conducted according to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent will be obtained from all individual participants included in the study. The final study protocol and informed consent have been reviewed and approved by the institutional ethics committee and by the Italian Medicines Agency (EudraCT 2019\u2013002391-13).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Piccolo reports personal fees from Abbott Vascular, Biotronik, and Daiichi-Sankyo, outside the submitted work. Dr. Gargiulo G reports personal fees from Daiichi-Sankyo, outside the submitted work. Dr. Di Serafino reports personal fees from Abbott Vascular and Hexacath, outside the submitted work. Dr. Esposito reports personal fees from Abbott Vascular, Amgen, Edwards Lifesciences, and Sanofi, outside the submitted work and research grants to the institution from Alvimedica, Boston Scientific, and Medtronic. The other authors have no conflicts of interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}